Catatan efek · kuartal yang diarsipkan
IBRX
ImmunityBio, Inc. · Healthcare · Biotechnology
15Pemegang yang dilacak
0Δ pemegang
77.60MSaham yang dipegang
$190.89MNilai yang dilaporkan
+2Posisi baru
−2Keluar
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +19.4% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +5 | 153.88M | $1.35B | +10 | −5 |
| Q1 2026 | 103 | +11 | 130.83M | $998.92M | +19 | −8 |
| Q4 2025 | 91 | -1 | 143.54M | $283.94M | — | −1 |
| Q3 2025 | 15 | 0 | 77.60M | $190.89M | +2 | −2 |
| Q2 2025 | 12 | +1 | 58.35M | $154.05M | +1 | — |
| Q1 2025 | 8 | 0 | 12.96M | $39.01M | +1 | −1 |
| Q4 2024 | 8 | +1 | 14.27M | $36.54M | +2 | −1 |
| Q3 2024 | 6 | 0 | 5.93M | $22.06M | +1 | −1 |
| Q2 2024 | 6 | — | 4.42M | $27.95M | — | — |
Siapa yang memegangnya · Q3 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasif) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasif) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasif) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (pasif) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasif) | 11.32M | +48.6% | $27.84M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasif) | 6.89M | +19.3% | $16.95M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (pasif) | 6.89M | +19.3% | $16.95M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 2.61M | +224.9% | $6.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Goldman Sachs Group ✦ | 1.14M | — | $2.81M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Goldman Sachs Group ✦ | 1.14M | — | $2.81M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 1.13M | +43.8% | $2.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | Citadel Advisors ✦ | 1.13M | +43.8% | $2.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Renaissance Technologies ✦ | 1.02M | Baru | $2.50M | 0.0% | New | 1 | SEC ↗ |
| 43 | Marshall Wace ✦ | 254.81K | Baru | $626,844 | 0.0% | New | 1 | SEC ↗ |
| 44 | T. Rowe Price ✦ | 121.05K | +5.3% | $298,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 103.78K | -34.8% | $255,296 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 103.78K | -34.8% | $255,296 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 103.78K | -34.8% | $255,296 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 103.78K | -34.8% | $255,296 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 49 | Millennium Management ✦ | 48.30K | -98.5% | $118,808 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 50 | Fidelity (FMR) ✦ | 10.91K | -22.8% | $26,848 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Renaissance Technologies | $2.50M | 0.0% |
| Marshall Wace | $626,844 | 0.0% |
Telah keluar
| D. E. Shaw & Co. | $626,068 | adalah 0.0% |
| Gotham Asset Management | $42,831 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 383 pemegang, 176.43M saham, $1.31B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2025 ·
Metodologi ·
Dapatkan ini melalui API